Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This pilot study is designed to address feasibility for a larger randomized control clinical study that will determine the efficacy of exposure to the MindfulGarden - an interactive digital technology - in reducing hyperactive delirium in hospitalized older adults.
The primary objective of the study is to establish whether the key components necessary for conducting a full randomized control study in the future, such as recruitment, consent, randomization, and treatment processes are working well and all function together. As a secondary objective, the investigators will determine trends in patients exposed to MindfulGarden (MG), for example:
Additionally, to the extent that movement and vocalization are reflective of anxiety, agitation and/or aggression (i.e. responsive behaviours) the investigators also want to determine whether there is a correlation between changes in these as recorded by the MG and any of the indicators listed in 1-6 above.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MindfulGarden | Experimental | Standard care + exposure to an interactive digital device |
|
| Control | No Intervention | Standard care only |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MindfulGarden | Device | MindfulGarden (MG) is an interactive digital technology that combines use of a smart television with sensors to intelligently generate content based on patient voice and gesture input, triggering a multi-layered visual 'garden' on-screen to arrest and de-escalate anxiety and aggression in treatment of hospitalized elderly diagnosed with hyperactive delirium. |
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment Rates | Number of participants approached and their rate of consent | Number enrolled within 12 hours of admission to Emergency Department |
| Measure | Description | Time Frame |
|---|---|---|
| Estimate the potential effect size | MG association with reducing delirium duration as measured CAM - short | 24-hour period following transfer from Emergency Department |
| Adverse Outcomes (number of patients with aggressive/violent behaviours, falls, code white) |
Not provided
Inclusion Criteria:
- All patients aged 65 years or older admitted to the Emergency Department who have a diagnosis of hyperactive delirium as defined by the short CAM
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Gloria Gutman, PhD | Contact | 778.782.5063 | gutman@sfu.ca | |
| Fabio Feldman, PhD | Contact | 6045877850 | fabio.feldman@fraserhealth.ca |
| Name | Affiliation | Role |
|---|---|---|
| Gloria Gutman | Simon Fraser University | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003693 | Delirium |
| D013035 | Spasm |
| D000374 | Aggression |
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D003221 | Confusion |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Assess from patients medical chart |
| 24-hour period following transfer from Emergency Department |
| Psychotropic Drug Consumption | Assess from patient's medical chart | 24-hour period following transfer from Emergency Department |
| Application of Physical Restraints | Assess from patient's medical chart | 24-hour period following transfer from Emergency Department |
| Length of Stay | Assess from patient's medical chart | Date of study enrolment through to discharge from hospital, or date of study enrolment up to 30 days |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D020879 | Neuromuscular Manifestations |
| D000096762 | Aberrant Motor Behavior in Dementia |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D012919 | Social Behavior |